{
  "id": "81a9084758d5a87a",
  "title": "STAT+: Pharmalittle: We\u2019re reading about AstraZeneca investing in China, an abandoned overdose antidote, and more",
  "description": "AstraZeneca\u00a0will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development",
  "content": "AstraZeneca\u00a0will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/29/astrazeneca-hologen-kickbacks-overdose-lilly-china/?utm_campaign=rss",
  "published_at": "2026-01-29T14:23:35+00:00",
  "fetched_at": "2026-01-30T00:27:47.504790+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "manufacturing",
    "china"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about AstraZeneca investing in China, an abandoned overdose antidote, and more",
    "description": "AstraZeneca\u00a0will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development",
    "url": "https://www.statnews.com/pharmalot/2026/01/29/astrazeneca-hologen-kickbacks-overdose-lilly-china/?utm_campaign=rss",
    "published": "2026-01-29T14:23:35+00:00",
    "source": "STAT"
  }
}